These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Gleicher N; Elkayam U Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848 [TBL] [Abstract][Full Text] [Related]
6. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block. Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310 [TBL] [Abstract][Full Text] [Related]
12. Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Routsias JG; Kyriakidis NC; Friedman DM; Llanos C; Clancy R; Moutsopoulos HM; Buyon J; Tzioufas AG Arthritis Rheum; 2011 Sep; 63(9):2783-9. PubMed ID: 21618202 [TBL] [Abstract][Full Text] [Related]
13. Health Outcomes of 215 Mothers of Children With Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry. Miniaoui I; Morel N; Lévesque K; Maltret A; Driessen M; Masseau A; Orquevaux P; Piette JC; Barriere F; Le Bidois J; Georgin-Lavialle S; Guettrot-Imbert G; Le Guern V; Mouthon L; Jallouli M; Deligny C; Hachulla E; Romefort B; ; Bonnet D; Costedoat-Chalumeau N J Rheumatol; 2022 Oct; 49(10):1124-1130. PubMed ID: 35501147 [TBL] [Abstract][Full Text] [Related]
14. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center. Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874 [TBL] [Abstract][Full Text] [Related]
15. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164 [TBL] [Abstract][Full Text] [Related]
16. [Neonatal lupus syndrome: Literature review]. Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481 [TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy. Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Friedman DM; Llanos C; Izmirly PM; Brock B; Byron J; Copel J; Cummiskey K; Dooley MA; Foley J; Graves C; Hendershott C; Kates R; Komissarova EV; Miller M; Paré E; Phoon CK; Prosen T; Reisner D; Ruderman E; Samuels P; Yu JK; Kim MY; Buyon JP Arthritis Rheum; 2010 Apr; 62(4):1138-46. PubMed ID: 20391423 [TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]